Of all the procedures plastic surgeons perform, a properly performed facial peel, often following a facelift, gives the most dramatic improvement to the facial appearance of a patient. A chemical peel improves fine wrinkles, brown age spots, roughened sunspots, pigment abnormalities and many other age and sun-related conditions. Over the last several years, there have been many procedural improvements, making it safer and more comfortable for patients. Additionally, a more conservative type of "light peel" yields better results with less recovery time. The chemical peel procedure involves selecting a particular peel solution and the manner with which it is applied. In addition to the face and neck, arms and hands doctors can treat arms and hands with equal ease. Peeling agents can include TCA, glycolic acid, kojic acid, phenol and croton oil. Doctors combine the chemical peel with other facial rejuvenation procedures such as carbon dioxide or IPL lasers and dermabrasion for optimal results. Patients with an active tan should typically wait for two weeks before receiving a chemical peel in order to minimize the risk of pigmentation irregularities. Those with a history of oral herpes simplex virus infection will need to take an antiviral medication for two days before a peel procedure in order to minimize any risk of recurrence. A typical skin care regimen includes: Retin-A 0.05%, skin rejuvenation cream applied three times a week, nightly; Glyquin, bleaching agent containing Glycolic acid for to exfoliate the skin, applied every day and night; Vitamin C acid, skin rejuvenation agent and an antioxidant, applied in the morning. Physicians perform peels that are more superficial with a topical anesthesia or strong numbing cream. The doctor applies the cream to the to face or hands of the patient 15 minutes before a procedure and is simply washed off when the doctor finishes the procedure. The doctor cleanses the skin and pores of the patient with a specialized solution. The doctor gently applies a peeling solution consists of a customized mixture of trichloroacetic acid, glycolic acid or koji acid to the face of the patient. After the desired effect, the patient washes off the peeling agent and applies a strong moisturizer to return moisture to the skin without blocking pores.

More Resources

Substance-related disorders

Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, also known as DSM-IV-TR, is a manual published by the American Psychiatric Association (APA) that includes all currently recognized mental health disorders. The coding system utilized by the DSM-IV is designed to correspond with codes from the International Classification of Diseases, commonly referred to as the ICD. Since early versions of the DSM did not correlate with ICD codes and updates of the publications for the ICD and the DSM are not simultaneous, some distinctions in the coding systems may still be present. For this reason, it is recommended that users of these manuals consult the appropriate reference when accessing diagnostic codes.

Alcohol-related disorders

• Alcohol
  • 305.00 Abuse
  • 303.90 Dependence
  • 291.8 -Induced anxiety disorder
  • 291.8 -Induced mood disorder
  • 291.1 -Induced persisting amnestic disorder
  • 291.2 -Induced persisting dementia
  • 291.5 -Induced psychotic disorder, with delusions
  • 291.3 -Induced psychotic disorder, with hallucinations
  • 291.8 -Induced sexual dysfunction
  • 291.8 -Induced sleep disorder
  • 303.00 Intoxication
  • 291.0 Intoxication delirium
  • 291.9 -Related disorder NOS
  • 291.8 Withdrawal
  • 291.0 Withdrawal delirium

Amphetamine (or amphetamine-like) related disorders

• Amphetamine (or amphetamine-like)
  • 305.70 Abuse
  • 304.40 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.84 -Induced mood disorder
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 -Induced sexual dysfunction
  • 292.89 -Induced sleep disorder
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS (includes Amphetamine Withdrawal Psychosis)
  • 292.0 Withdrawal

Caffeine-related disorders

• Caffeine
  • 292.89 -Induced anxiety disorder
  • 292.89 -Induced sleep disorder
  • 305.90 Intoxication
  • 292.9 -Related disorder NOS

Cannabis-related disorders

• Cannabis
  • 305.20 Abuse
  • 304.30 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS

Cocaine-related disorders

• Cocaine
  • 305.60 Abuse
  • 304.20 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.84 -Induced mood disorder
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 -Induced sexual dysfunction
  • 292.89 -Induced sleep disorder
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS
  • 292.0 Withdrawal

Hallucinogen-related disorders

• Hallucinogen
  • 305.30 Abuse
  • 304.50 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.84 -Induced mood disorder
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.89 -persisting perception disorder
  • 292.9 -Related disorder NOS

Inhalant-related disorders

• Inhalant
  • 305.90 Abuse
  • 304.60 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.84 -Induced mood disorder
  • 292.82 -Induced persisting dementia
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS

Nicotine-related disorders

• Nicotine
  • 305.1 Dependence
  • 292.9 -Related disorder NOS
  • 292.0 Withdrawal

Opioid-related disorders

• Opioid
  • 305.50 Abuse
  • 304.00 Dependence
  • 292.84 -Induced mood disorder
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 -Induced sexual dysfunction
  • 292.89 -Induced sleep disorder
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS
  • 292.0 Withdrawal

Phencyclidine (or phencyclidine-like) related disorders

• Phencyclidine (or phencyclidine-like)
  • 305.90 Abuse
  • 304.90 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.84 -Induced mood disorder
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS

Sedative-, hypnotic-, or anxiolytic-related disorders

• Sedative, hypnotic, or anxiolytic
  • 305.40 Abuse
  • 304.10 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.84 -Induced mood disorder
  • 292.83 -Induced persisting amnestic disorder
  • 292.82 -Induced persisting dementia
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 -Induced sexual dysfunction
  • 292.89 -Induced sleep disorder
  • 292.89 Intoxication
  • 292.81 Intoxication delirium
  • 292.9 -Related disorder NOS
  • 292.0 Withdrawal
  • 292.81 Withdrawal delirium

Polysubstance-related disorder

• 304.80 Polysubstance dependence

Other (or unknown) substance-related disorder

• Other (or unknown) substance
  • 305.90 Abuse
  • 304.90 Dependence
  • 292.89 -Induced anxiety disorder
  • 292.81 -Induced delirium
  • 292.84 -Induced mood disorder
  • 292.83 -Induced persisting amnestic disorder
  • 292.82 -Induced persisting dementia
  • 292.11 -Induced psychotic disorder, with delusions
  • 292.12 -Induced psychotic disorder, with hallucinations
  • 292.89 -Induced sexual dysfunction
  • 292.89 -Induced sleep disorder
  • 292.89 Intoxication
  • 292.9 -Related disorder NOS
  • 292.0 Withdrawal